Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 0378-0094

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 0378-0094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 25 mg/100 mg Bottle Label (Image 01)

This is a medication description for a drug called "Carbidopa and Levodopa Extended-Release". Each tablet contains a combination of carbidopa and levodopa. The drug comes in a tightly sealed, light-resistant container. The text also includes dosage information indicating there are 100 tablets in the container. It appears to be manufactured by Mylan Pharmaceuticals.*

FDA Label Image

Carbidopa And Levodopa Extended-release Tablets, Usp 50 mg/200 mg Bottle Label (Image 02)

This is a medication package for Carbidopa and Levodopa Extended-Release Tablets, USP. It contains 100 tablets of 50 mg/ dose. The medication is resistant to moisture and acts as a disease inhibitor. The container should be kept closed and out of the reach of children, and stored at a temperature of 25°C. The prescription details are provided by the manufacturer Mylan Pharmaceuticals, which is located in Morgantown, WY in the United States.*

FDA Label Image

Carbidopa Structural Formula (Image 03)

FDA Label Image

Levodopa Structural Formula (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.